These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16844732)

  • 21. Decline in cervical cancer incidence and mortality in New South Wales in relation to control activities (Australia).
    Taylor R; Morrell S; Mamoon H; Wain G; Ross J
    Cancer Causes Control; 2006 Apr; 17(3):299-306. PubMed ID: 16489537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of causes of increased incidence of cervical cancer in Slovenia.
    Smrkolj S; Rakar S; Mozina A; Erzen M
    Eur J Obstet Gynecol Reprod Biol; 2004 Dec; 117(2):213-21. PubMed ID: 15541860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of inequalities in cervical cancer stage at diagnosis and survival in New Zealand.
    Priest P; Sadler L; Sykes P; Marshall R; Peters J; Crengle S
    Cancer Causes Control; 2010 Feb; 21(2):209-14. PubMed ID: 19847659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995.
    Sigurdsson K
    Acta Obstet Gynecol Scand; 1999 Jul; 78(6):478-85. PubMed ID: 10376856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The German cervical cancer screening model: development and validation of a decision-analytic model for cervical cancer screening in Germany.
    Siebert U; Sroczynski G; Hillemanns P; Engel J; Stabenow R; Stegmaier C; Voigt K; Gibis B; Hölzel D; Goldie SJ
    Eur J Public Health; 2006 Apr; 16(2):185-92. PubMed ID: 16469759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
    Yang B; Morrell S; Zuo Y; Roder D; Tracey E; Jelfs P
    Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Updated cervical cancer screening; human papilloma virus and Papanicolaou tests].
    Sasagawa T
    Rinsho Byori; 2009 Sep; 57(9):905-12. PubMed ID: 19860220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of cervical cancer screening in Scandinavia.
    Day NE
    Obstet Gynecol; 1984 May; 63(5):714-8. PubMed ID: 6717876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in cancer of the cervix uteri in Sweden following cytological screening.
    Bergström R; Sparén P; Adami HO
    Br J Cancer; 1999 Sep; 81(1):159-66. PubMed ID: 10487628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cervical cancer in New Zealand: national and regional trends.
    Cox B; Borman B
    N Z Med J; 1994 Aug; 107(984):323-6. PubMed ID: 8072727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Green tea consumption and mortality among Japanese elderly people: the prospective Shizuoka elderly cohort.
    Suzuki E; Yorifuji T; Takao S; Komatsu H; Sugiyama M; Ohta T; Ishikawa-Takata K; Doi H
    Ann Epidemiol; 2009 Oct; 19(10):732-9. PubMed ID: 19628408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Body mass index and mortality in women: follow-up of the Canadian National Breast Screening Study cohort.
    Jain MG; Miller AB; Rohan TE; Rehm JT; Bondy SJ; Ashley MJ; Cohen JE; Ferrence RG
    Int J Obes (Lond); 2005 Jul; 29(7):792-7. PubMed ID: 15809663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Body mass index and mortality among older breast cancer survivors in the Study of Osteoporotic Fractures.
    Reeves KW; Faulkner K; Modugno F; Hillier TA; Bauer DC; Ensrud KE; Cauley JA;
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1468-73. PubMed ID: 17627012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
    Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
    Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Education in relation to incidence of and mortality from cancer and cardiovascular disease in Japan.
    Ito S; Takachi R; Inoue M; Kurahashi N; Iwasaki M; Sasazuki S; Iso H; Tsubono Y; Tsugane S;
    Eur J Public Health; 2008 Oct; 18(5):466-72. PubMed ID: 18628318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
    Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
    J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cervical cancer in Croatia: state of the art and possibilities for prevention.
    Znaor A; Strnad M
    Coll Antropol; 2007 Apr; 31 Suppl 2():37-40. PubMed ID: 17598503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes mellitus and kidney cancer risk: the results of Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC Study).
    Washio M; Mori M; Khan M; Sakauchi F; Watanabe Y; Ozasa K; Hayashi K; Miki T; Nakao M; Mikami K; Ito Y; Kubo T; Wakai K; Tamakoshi A;
    Int J Urol; 2007 May; 14(5):393-7. PubMed ID: 17511719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Participation in cervical cancer screening by age and region--a cohort study with a 3 1/2 year follow-up on 2,223,135 women in Bavaria.
    Rückinger S; Tauscher M; Redel R; Munte A; Walchner-Bonjean M; Hess J; Schneider A; von Kries R
    Gesundheitswesen; 2008 Jun; 70(6):e17-21. PubMed ID: 18661453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.